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Objective: To study the effects of Aidi Dripping Pills on immune functions of the tumor-bearing mouse on 
the basis of the previous experimental studies on its tumor-inhibiting and life-prolonging effects. Methods:
By using the transplantation tumor mouse models, the effects of Aidi Dripping Pills on the lymphocyte 
transformation rate and the hemolysin formation in the S180 tumor-bearing mice, and on the phagocytic 
function of macrophages in the abdominal cavity of H22 tumor-bearing mice were investigated. Results: In 
the 2.25 g/kg and 1.125 g/kg Aidi Dripping Pills groups, the lymphocyte transformation rates in the S180 
tumor-bearing mice were significantly higher than that of the control group (P<0.01). In all the Aidi Dripping 
Pills groups, HC50 significantly increased (P<0.01 or P<0.05), carbon granular clearance significantly raised, 
and both the phagocytic index and phagocytic coefficient were significantly higher than those in the control 
group (P<0.01 or P<0.05). Conclusion: The Aidi Dripping Pills can significantly increase the cellular 
immune function, the humoral immune function and the phagocytic function of the mononuclear- 
macrophages, so it may show anti-tumor effects by enhancing the function of the reticuloendothelial system. 
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The Aidi Dripping Pill1 is a transformed preparation 
according to the prescription of Aidi Injection2 by 
changing the pharmaceutical technique. Because the 
injection may cause pain and allergic reaction, and it 
is inconvenient in use, and complicated in 
preparation, so the reform of dosage form is 
necessary. The Aidi Injection has the functions of 
clearing away heat and toxic material, removing 
blood stasis and resolving mass, which is clinically 
used for treatment of primary liver cancer and lung 
cancer, with marked therapeutic effects. In the 
present study, the effects of Aidi Dripping Pills on 
immune functions of the tumor-bearing mouse were 
studied, so as to provide a sound basis for changing 
the dosage form.3 
EXPERIMENTAL MATERIALS
Animals and Tumor Strains1  
The Kunming mice, either male or female, weighing 
18 g–22 g (Conformity Certificate No.: SCXK (ݯ) 
2002–2005), the mouse S180 tumor-bearing cell strain 
and the mouse H22 tumor-bearing cell strain were all 
purchased from the Experimental Animals Center, 
the Fourth Military Medical University. 
Drugs Used 
The Aidi Dripping Pills, composed of Ban Mao (⧁
㴹Mylabris) 1.5g, Renshen (Ҏখ Ginseng) 50g and
Huangqi (咘㡾 Radix Astragali) 100g, were supplied 
                                                       
Correspondence to: Prof. QU Yun-zhi 
Email: yunzhiq@sina.com 
Tel: 86-10-61505425 
Journal of Traditional Chinese Medicine, June 2010, Vol. 30, No. 2 123
by Beijing Zhengda Luzhou Medical Science and 
Technology Development Co., Ltd. (made on March 
20, 2007). The Aidi Injection with the same 
prescription as Aidi Dripping Pills was made by 
Guizhou Yibai Pharmaceutical Co., Ltd. (Ratification 




The Aidi Injection of 50–100 ml/day corresponds to 
the crude drug 15.075–30.15 g, and one of the 
dripping pills corresponds to the crude drug 1.5075g, 
so the 50–100ml, injection dose is equal to 10–20 
Dripping Pills in content of the crude drug. The three 
oral doses of the dripping pills 60 pills/day, 30 
pills/day and 15 pills/day were determined by a 
preparative experiment, which were respectively 
equal to 2.25 g/kg, 1.125 g/kg and 0.5625 g/kg for 
the mice by conversion according to the body surface 
area.    
Detection of Lymphocyte Transformation Rate in 
the S180 Tumor-bearing Mice
According to the methods described in literature 
3,4,6,7, 60 female mice, weighing 18–22g, were 
randomly divided into 5 groups, a tumor-bearing 
control group (oral saline 20 ml/kg), a positive 
control group (Aidi Injection 16.7 ml/kg), and Aidi
dripping Pills 2.25 g/kg, 1.125 g/kg and 0.5625 g/kg 
groups, 12 mice in each group. Each mouse was 
inoculated with the S180 tumor cells. Method: The 
relatively healthy mouse of ascites with the S180
tumor cells growing 7–10 days was killed by 
decapitation, the S180 tumor cell solution (1x107/ml) 
was prepared under aseptic operation, and then the 
tumor cell solution of 0.2 ml was subcutaneously 
inoculated into the right fore limb axillary fossa of 
the mouse to be tested. The drugs were administrated 
from the next day after the inoculation, once a day, 
for 10 consecutive days. In the three days before the 
end of administration, the mouse in each group were 
given intramuscular injection of PHA, 10 mg/kg 
each day. One hour after the end of administration, 
the mice tail was cut and the blood was taken for 
smear and Wright’s staining in each group. Then, 
100 lymphocytes were countered under an oil imm- 
ersion objectives and the percentages of the lym- 
phoblasts and transient lymphocytes were calculated.  
Test for Hemolysin Formation in the S180 Tumor- 
bearing Mice
According to the methods described in literature 
3,4,6,7, 50 male mice, weighing 18 g–22 g, were 
randomly divided into 5 groups, a tumor-bearing 
control group (oral saline 20 ml/kg), a positive 
control group (Aidi Injection 16.7 ml/kg), and Aidi
Dripping Pills 2.25 g/kg, 1.125 g/kg and 0.5625 g/kg 
groups, 10 mice in each group. The S180 sarcoma was 
inoculated with the above-mentioned method. From 
the next day after the inoculation, the drugs were 
administrated, once a day, for 10 consecutive days.
On the fourth day after the administration, 0.2 ml of 
10% sheep red blood cell (SRBC) suspension was 
injected into the abdominal cavity of each mouse. 
The next day after last administration, 1 ml blood 
was taken from the angular vein plexus, and the 
serum was separated and diluted to 100 folds with 
saline.1ml of the diluted serum, 0.5 ml of 10% sheep 
red blood suspension (about 1010cells) and 1 ml of 
10% guinea pig complement were mixed and 
incubated in a water bath at 37ć for 10 minutes, 
and then immediately put in an ice bath for ending 
the reaction, which was centrifuged at 2000 rpm for 
10 minutes and 1 ml supernatant was mixed with 
3hml Dobois’s reagent. 10 minutes later, OD540nm of 
each tube was measured and HC50 was calculated. 
The intergroup comparison was conducted with 
t-test. 
Detection of the Phagocytic Function of Macro- 
phages in the Abdominal Cavity of the S180 
Tumor- baring Mouse 
According to the methods described in literature 
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3,4,6,7, 60 male mice, weighing 18 g–22 g, were 
randomly divided into 5 groups, a tumor-bearing 
control group (oral saline 20 ml/kg), a positive 
control group (Aidi Injection 16.7 ml/kg), and Aidi
Dripping Pills 2.25 g/kg, 1.125 g/kg and 0.5625 g/kg 
groups, 12 mice in each group. The S180 sarcoma was 
inoculated with the above-mentioned method. From 
the next day after the inoculation, the drugs were 
administrated, once a day, for 10 consecutive days. 
The next day after the last administration, the mice 
were weighted and 10% diluted India ink saline was 
respectively injected into the tail vein (0.1 ml/g). 2 
and 12 minutes later, 20ȝl blood was res- pectively 
taken from the angular vein plexus with a 
micropipette and immediately poured into 2 ml 0.1% 
Na2CO3 solution and mixed. Then, OD680nm was read 
with a 721 spectrophotometer; and the liver and 
spleen were taken and weighted for calculating the 
phagocytic index ț and the phagocytic coefficient Į . 
RESULTS 
Effect of the Aidi Dripping Pills on Lymphocyte 
Transformation Rate in the S180 Tumor-bearing 
Mice
It can be seen from Table 1 that the lymphocyte 
transformation rates in the Aidi Dripping Pills 1.125 
and 2.25 g/kg groups and in the Aidi Injection 
16.7gml/kg group were significantly higher than that 
of the tumor-bearing control group (all P<0.01), 
indicating that the Aidi Dripping Pills can sig- 
nificantly promote transformation ability of the 
lymphocytes in the S180 tumor-bearing mice 
stimulated by PHA, with a strengthening effect on 
cellular immune function. 
Effect of the Aidi Dripping Pills on Hemolysin 
Formation in the S180 Tumor-bearing Mice 
Table 2 shows that the Aidi Dripping Pills 0.5625 
g/kg, 1.125 g/kg, 2.25 g/kg and the Aidi Injection 
16.7 ml/kg can significantly increase HC50 of the 
S180 tumor-bearing mice (P<0.01 or P<0.05), in- 
dicating that the Aidi Dripping Pills can promote 
hemolysin antibody formation in the S180 tumor- 
bearing mice, with a strengthening effect on humoral 
immunity. 
Effect of the Aidi Dripping Pills on Phagocytic 
Function of Macrophages in Abdominal Cavity of 
the S180 Tumor-bearing Mice
As shown in Table 3, the phagocytic indexes in the 
Aidi Dripping Pills 0.5625 g/kg, 1.125 g/kg and 2.25 
g/kg groups and in the Aidi Injection 16.7 ml/kg 
group were significantly higher than that of the 
tumor-bearing control group (P<0.01 or P<0.05); the 
phagocytic coefficients in the Aidi Dripping Pills 
1.125 g/kg and 2.25 g/kg groups and in the Aidi
Injection 16.7 ml/kg group were significantly higher 
than that of the tumor-bearing control group 
(P<0.01), indicating that the Aidi Dripping Pills can 
significantly increase the carbon granular clearance 
ability, with a strengthening effect on phagocytic 
function of the reticulo-endothelial system in the 
tumor-bearing mice. 
Table 1. Effect of the Aidi Dripping Pills on the lymphocyte transformation rate 
 in the S180 tumor-bearing mice (n=12, x fs) 
Group Dose 
 (g/kg) 
Body weight (g) 
(Before / after) 
Transformation rate of lymphocyte
 (%) 
Tumor-bearing control Saline (20 ml/kg) 20.50±1.54 / 26.08±2.94 36.50±5.16 
Aidi Dripping Pills 0.5625 20.83±1.75 / 24.58±2.39 40.17±4.80 
Aidi Dripping Pills 1.125 20.83±1.75 / 25.08±2.71   42.25±3.75** 
Aidi Dripping Pills 2.25 20.92±1.73 / 26.58±3.85   44.50±6.40** 
Aidi Injection 16.7 ml/kg 20.92±1.73 / 28.00±3.22   47.33±6.36** 
Note: Compared with the tumor-bearing control group, **P<0.01. 
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Table 2. Effect of the Aidi Dripping Pills on hemdysin formation in the 
S180 tumor-bearing mice (n=10, x fs) 
Group Dose (g/kg) HC50
Tumor-bearing control Saline (20 ml/kg) 45.00±18.87
Aidi Dripping Pills 0.5625  64.57±17.39*
Aidi Dripping Pills 1.125   70.00±19.79**
Aidi Dripping Pills 2.25  76.20±8.40**
Aidi Injection 16.7 ml/kg  73.91±9.61**
Note: Compared with the tumor-bearing control group,*P<0.05, **P<0.01.
Table 3. Effect of the Aidi Dripping Pills on phagocytosis of macrophages in abdominal cavity of  
the S180 tumor-bearing mice (n=12, x fs) 
Group Dose(g/kg) The Liver-spleen weight (g) Phagocytic index (ț, x10-2) Phagocytic coefficient (Į )
Tumor-bearing Control Saline(20ml/kg) 2.35±0.15 1.24±0.77 2.51±1.47
Aidi Dripping Pills 0.5625 2.21±0.23 2.22±0.13* 3.45±0.73
Aidi Dripping Pills 1.125 2.39±0.35  3.11±0.69**   3.80±0.56**
Aidi Dripping Pills 2.25 2.15±0.57  3.87±1.05**   4.40±0.48**
Aidi Injection 16.7 ml/kg   2.55±0.17**  3.77±0.99**   3.91±0.46**
Note: Compared with the tumor-bearing control group, *P<0.05, **P<0.01. 
DISCUSSION 
The Dripping Pills preparation may show such 
characteristics as high effect, rapid effect and 
convenient administration. The Aidi Injection has 
been used for clinical treatment of the primary liver 
cancer and the lung cancer, with marked therapeutic 
effects; but it is inconvenient in use, and may cause 
pain and allergic reaction. Therefore, we try to 
change the Aidi Injection into the Aidi Dripping Pills. 
The present pharmacodynamic study has demon- 
strated that the Aidi Dripping Pills 2.25g/kg and 
1.125g/kg can significantly increase the lymphocyte 
transformation rate in the S180 tumor- bearing mice; 
and 0.5625g/kg, 1.125g/kg and 2.25g/kg can 
significantly raise the HC50 and carbon granular 
clearance ability in the S180 tumor-bearing mice. It is 
suggested that the Aidi Dripping Pills may show the 
anti-tumor effects possibly by enhancing the cellular 
immune function, the humeral immunity and the 
non-special immune function. 
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